SYNERGY™ XD

Everolimus-Eluting Platinum Chromium Coronary Stent System

play icon
Introducing SYNERGY™ XD
The SYNERGY™ XD BP Stent
FIRST and ONLY 48 mm DES in the U.S.
Indicated for use in High Bleeding Risk patients*
synchronous drug elution and polymer absorption
Introducing SYNERGY™ XD
The SYNERGY™ XD BP Stent features an innovative delivery system for Xtra Deliverability.
Size matrix includes the FIRST and ONLY 48 mm DES in the U.S.
Indicated for use in High Bleeding Risk patients*
Unlike permanent polymer DES technology, the SYNERGY™ XD BP Stent features synchronous drug elution and polymer absorption for optimal healing.

Delivering More.

Xtra Deliverability. Optimal Healing.

Introducing the next generation SYNERGY™ Bioabsorbable Polymer (BP) Stent. The SYNERGY™ XD Stent System is equipped with a delivery system designed to make optimal healing even more deliverable.

Explore

 

Visibility

 

Why Visibility is Important

Good visualization is key for accurate placement and optimal outcomes. Stent misplacement at the ostium occurs frequently and is associated with higher rates of restenosis and target lesion revascularization (TLR).*

SYNERGY Visibility Pie Chart
True ostium was missed in 54% of cases.*
 

See the difference

Even with thin struts, the high density of Platinum Chromium allows for greater visibility.

 
SYNERGY Visibility Chart
 
 

Xtra Deliverability

 

Innovative Delivery System

The SYNERGY™ XD BP Stent System combines added trackability and pushability with a low-profile stent platform to enable better navigation of challenging anatomy.

 
Xtra Deliverability
 

SYNERGY™ XD 48 mm

 
 

Quality Outcomes for Patients

1-year results from the EVOLVE 48 Trial support the safety and effectiveness of the SYNERGY™ XD 48 mm BP Stent for the treatment of long lesions**2

Quality Outcomes for Patients, SYNERGY XD product shot
 

Studying DAPT

Indicated for Use in High Bleeding Risk Patients††

The SYNERGY™ BP Stent can be safely used in conjunction with shortened DAPT in patients at high risk for bleeding (HBR), based on the results from the EVOLVE Short DAPT Trial. This trial data in conjunction with the HBR indication, provides important evidence to inform decisions about DAPT duration for this patient subset.

 

EVOLVE Short DAPT Trial ‡‡³

Studying 3-month DAPT in high bleeding risk patients
 
 

Optimal Healing

Fast Absorbing Bioabsorbable Polymer Advantage

Unlike permanent polymer DES technology, the SYNERGY™ XD Bioabsorbable Polymer is gone shortly after the drug is completely eluted.4

 
 
 
 

Ordering Information

 

Stent Length (mm)

ø 

(mm)

81216202428323848

Expansion

Limit

2.25 H7493941708220H7493941712220H7493941716220H7493941720220H7493941724220H7493941728220H7493941732220H7493941738220 3.50
2.50 H7493941708250H7493941712250H7493941716250H7493941720250H7493941724250H7493941728250H7493941732250H7493941738250H74939417482503.50
2.75H7493941708270H7493941712270H7493941716270H7493941720270H7493941724270H7493941728270H7493941732270H7493941738270H74939417482703.50
3.00H7493941708300H7493941712300H7493941716300H7493941720300H7493941724300H7493941728300H7493941732300H7493941738300H74939417483004.25
3.50H7493941708350H7493941712350H7493941716350H7493941720350H7493941724350H7493941728350H7493941732350H7493941738350H74939417483504.25
4.00H7493941708400H7493941712400H7493941716400H7493941720400H7493941724400H7493941728400H7493941732400H7493941738400H74939417484005.75
4.50 H7493941712450H7493941716450H7493941720450H7493941724450H7493941728450H7493941732450  5.75
5.00 H7493941712500H7493941716500H7493941720500H7493941724500H7493941728500H7493941732500  5.75
 

Xtra Deliverability

Xtra Deliverability

Learn about the continued advancement in deliverability that SYNERGY™ XD offers

Button
SYNERGY™ XD 48 mm

SYNERGY™ XD 48 mm

Discover the First 48mm DES approved by US FDA

Button
Optimal Healing

Optimal Healing

Find out how synchronous drug elution and polymer absorption enables early healing

Button

Request a rep

Fill out a quick form and one of our sales representatives will be in touch.

Top